Note: The following article synopsis was NOT provided by AAPC. It was created by Find-A-Code/innoviHealth.
Article Overview
This brief Medicare-related update explains carrier guidance affecting home testing and incident-to drug reimbursement. It is useful for billing and coding staff, practice managers, and clinicians who need to understand the general scope of coverage policy changes discussed by the carrier. The article focuses on the coverage context, the organizations involved, and the types of services and drugs mentioned.
Why This Topic Matters
Coverage and reimbursement guidance from a Medicare carrier can affect how practices document, bill, and plan care for patients using anticoagulation-related services and therapies.
What You Will Learn
The general coverage issue addressed by the Medicare carrier
How the article frames home testing under carrier guidance
How the article characterizes incident-to reimbursement for certain drugs
Which carrier and policy context the update refers to
Who Should Read This
Medical coders
Billing staff
Practice managers
Clinicians
Revenue cycle professionals
Subscribe or sign in to view the full article.
Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.
Fully searchable archives - over 5150 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.
Related Articles
Articles are listed in order of calculated relevance.